Therapeutic immunization protections dopaminergic neurons in a mouse model of Parkison's disease
Christopher J. Destache(Creighton University), Howard E. Gendelman(Nebraska Medical Center), Vernice Jackson‐Lewis(Columbia University Irving Medical Center), Serge Przedborski(Columbia University), R. Lee Mosley(University of Nebraska Medical Center), Craig Nemachek(University of Nebraska Medical Center), Eric J. Benner(Duke University), Travis B. Lewis(Creighton University), Steven R. Green(Creighton University), Santhi Gorantla(Creighton University)
Proceedings of the National Academy of Sciences
January 1, 2004
Cited by 1
Related Papers
Oxidative stress and Parkinson’s disease
|Frontiers in Neuroanatomy|2015|870
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Diagnostics for SARS-CoV-2 infections
|Nature Materials|2021|838
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
|The Lancet Neurology|2015|508
α-Synuclein Is Localized to Mitochondria-Associated ER Membranes
|Journal of Neuroscience|2013|500